4 research outputs found

    The role of genetics in stroke risk factors; the discussion of two rare genetic syndroms associated with stroke and review of the literature

    No full text
    Stroke is defined as a focal or at times global neurological impairment of sudden onset, that lasts more than 24 hours or that leads to death. The nonmodifiable risk factors for stroke include age, race, gender and acquired risk factors include smoking, hypertension, diabetes and obesity. Previous studies have shown that these mentioned risk factors might be responsible for approximately 50% of patients presenting stroke. However for the remaining half of the stroke patients no risk factors could be detected and genetics might be responsible for this group. In this manuscript we would like to present 2 cases who were being followed-up with the rare genetic syndromes as Marfan syndrome and Robinow syndrome respectively. These patients presented to our clinic with stroke and no identifiable risk factors other than these genetic syndromes could be detected. By this case-series we would like to further discuss the relationship between genetic syndromes and stroke

    A Case of Neurosyphilis Presenting with Multiple Cranial Neuropathy

    No full text
    Syphilis is a sexually-transmitted disease caused by the spirochete bacterium Treponema pallidum. Central nervous system involvement can occur in every stage of the disease. It is classified into: acute syphilitic meningitis, meningovascular syphilis, and parenchymatous neurosyphilis. Acute basilar syphilitic meningitis is characterized primarily by the presence of cranial nerve involvement. As cranial nerve enhancement may be seen in a broad range of diseases, it can be the only clinical feature of neurosyphilis

    Real-life data from efficacy of fingolimod treatment in multiple sclerosis patients in Turkey

    No full text
    Bu çalışma, 14-17, Eylül 2016 tarihlerinde London[İngiltere]’ de düzenlenen 32. Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) Kongresi‘nde bildiri olarak sunulmuştur.European Comm Treatment & Res Multiple Sclerosi
    corecore